Naldini A - Search Results

1

Hedgehog Pathway Inhibition by Novel Small Molecules Impairs Melanoma Cell Migration and Invasion under Hypoxia.

Falsini A, Giuntini G, Mori M, Ghirga F, Quaglio D, Cucinotta A, Coppola F, Filippi I, Naldini A, Botta B, Carraro F. Falsini A, et al. Among authors: naldini a. Pharmaceuticals (Basel). 2024 Feb 8;17(2):227. doi: 10.3390/ph17020227. Pharmaceuticals (Basel). 2024. PMID: 38399442 Free PMC article.

2

Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis.

Leali D, Dell'Era P, Stabile H, Sennino B, Chambers AF, Naldini A, Sozzani S, Nico B, Ribatti D, Presta M. Leali D, et al. Among authors: naldini a. J Immunol. 2003 Jul 15;171(2):1085-93. doi: 10.4049/jimmunol.171.2.1085. J Immunol. 2003. PMID: 12847283

3

Bulk-preparation of hepatic binding protein.

Pessina GP, Naldini A, Bocci V. Pessina GP, et al. Among authors: naldini a. Ital J Biochem. 1986 Jan-Feb;35(1):16-21. Ital J Biochem. 1986. PMID: 3710764

4

Studies on tumor necrosis factor (TNF)--I. Pharmacokinetics of human recombinant TNF in rabbits and monkeys after intravenous administration.

Bocci V, Pacini A, Pessina GP, Maioli E, Naldini A. Bocci V, et al. Among authors: naldini a. Gen Pharmacol. 1987;18(4):343-6. doi: 10.1016/0306-3623(87)90088-7. Gen Pharmacol. 1987. PMID: 3609691

5

The lymphatic route. 1) Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasma.

Bocci V, Muscettola M, Grasso G, Magyar Z, Naldini A, Szabo G. Bocci V, et al. Among authors: naldini a. Experientia. 1986 Apr 15;42(4):432-3. doi: 10.1007/BF02118644. Experientia. 1986. PMID: 3956696

6

The lymphatic route--III. Pharmacokinetics of human natural interferon-beta injected with albumin as a retarder in rabbits.

Bocci V, Muscettola M, Naldini A. Bocci V, et al. Among authors: naldini a. Gen Pharmacol. 1986;17(4):445-8. doi: 10.1016/0306-3623(86)90189-8. Gen Pharmacol. 1986. PMID: 3758650

7

In vivo myelosuppression by combination interferon treatment: antagonism of MuIFN-gamma and MuIFN-beta myelosuppressive effects.

Naldini A, Fleischmann WR Jr. Naldini A, et al. J Biol Response Mod. 1987 Oct;6(5):546-55. J Biol Response Mod. 1987. PMID: 3119781

8

Pharmacokinetics of human lymphoblastoid interferon in rabbits.

Bocci V, Pessina GP, Pacini A, Paulesu L, Muscettola M, Naldini A, Lunghetti G. Bocci V, et al. Among authors: naldini a. Gen Pharmacol. 1985;16(3):277-9. doi: 10.1016/0306-3623(85)90083-7. Gen Pharmacol. 1985. PMID: 4018543

9

Studies on tumor necrosis factor (TNF): II. Metabolic fate and distribution of human recombinant TNF.

Pessina GP, Pacini A, Bocci V, Maioli E, Naldini A. Pessina GP, et al. Among authors: naldini a. Lymphokine Res. 1987 Winter;6(1):35-44. Lymphokine Res. 1987. PMID: 3821169

10

The lymphatic route--II. Pharmacokinetics of human recombinant interferon-alpha 2 injected with albumin as a retarder in rabbits.

Bocci V, Muscettola M, Naldini A, Bianchi E, Segre G. Bocci V, et al. Among authors: naldini a. Gen Pharmacol. 1986;17(1):93-6. doi: 10.1016/0306-3623(86)90017-0. Gen Pharmacol. 1986. PMID: 3949153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page